Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib

Bibliographic Details
Main Authors: Sara Saheb Kashaf, MPhil, Lucy A. Godley, MD, PhD, Angad Chadha, MD, Jason B. Waldinger, MD
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512623001200
_version_ 1797782690700722176
author Sara Saheb Kashaf, MPhil
Lucy A. Godley, MD, PhD
Angad Chadha, MD
Jason B. Waldinger, MD
author_facet Sara Saheb Kashaf, MPhil
Lucy A. Godley, MD, PhD
Angad Chadha, MD
Jason B. Waldinger, MD
author_sort Sara Saheb Kashaf, MPhil
collection DOAJ
first_indexed 2024-03-13T00:14:31Z
format Article
id doaj.art-7635fb0dbbd84b45a600851913790c9e
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-03-13T00:14:31Z
publishDate 2023-07-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-7635fb0dbbd84b45a600851913790c9e2023-07-12T04:19:47ZengElsevierJAAD Case Reports2352-51262023-07-0137119122Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinibSara Saheb Kashaf, MPhil0Lucy A. Godley, MD, PhD1Angad Chadha, MD2Jason B. Waldinger, MD3Pritzker School of Medicine, the University of Chicago, Chicago, IllinoisSection of Hematology/Oncology, Department of Medicine and Human Genetics, the University of Chicago, Chicago, IllinoisSection of Dermatology, Department of Medicine, the University of Chicago, Chicago, IllinoisPritzker School of Medicine, the University of Chicago, Chicago, Illinois; Division of Dermatology, Department of Medicine, NorthShore University & Health System, Evanston, Illinois; Correspondence to: Jason B. Waldinger, MD, Clinical Assistant Professor of Dermatology, University of Chicago, Division Head, Division of Dermatology, Department of Medicine, NorthShore University & Health System, 71 Waukegan Rd., Suite 700, Lake Bluff, IL 60044.http://www.sciencedirect.com/science/article/pii/S2352512623001200alopeciachronic myeloproliferative neoplasmgermline SDHC mutationripretinibsystemic mastocytosis
spellingShingle Sara Saheb Kashaf, MPhil
Lucy A. Godley, MD, PhD
Angad Chadha, MD
Jason B. Waldinger, MD
Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
JAAD Case Reports
alopecia
chronic myeloproliferative neoplasm
germline SDHC mutation
ripretinib
systemic mastocytosis
title Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_full Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_fullStr Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_full_unstemmed Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_short Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
title_sort systemic mastocytosis in the context of a deleterious germline sdhc variant treated with ripretinib
topic alopecia
chronic myeloproliferative neoplasm
germline SDHC mutation
ripretinib
systemic mastocytosis
url http://www.sciencedirect.com/science/article/pii/S2352512623001200
work_keys_str_mv AT sarasahebkashafmphil systemicmastocytosisinthecontextofadeleteriousgermlinesdhcvarianttreatedwithripretinib
AT lucyagodleymdphd systemicmastocytosisinthecontextofadeleteriousgermlinesdhcvarianttreatedwithripretinib
AT angadchadhamd systemicmastocytosisinthecontextofadeleteriousgermlinesdhcvarianttreatedwithripretinib
AT jasonbwaldingermd systemicmastocytosisinthecontextofadeleteriousgermlinesdhcvarianttreatedwithripretinib